Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
FBRX - Forte Biosciences, Inc.
Market Cap 20.24M P/E - EPS this Y 10.00% Ern Qtrly Grth -
Income -35.76M Forward P/E -0.15 EPS next Y 18.90% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 0.61 EPS next 5Y - 52W High Chg -30.00%
Recommedations 2.00 Quick Ratio 2.69 Shares Outstanding 1.46M 52W Low Chg 7.00%
Insider Own 10.88% ROA -81.25% Shares Float 883.64K Beta 1.45
Inst Own 55.85% ROE -170.91% Shares Shorted/Prior 3.37K/0.93K Price 0.96
Gross Margin - Profit Margin - Avg. Volume 69,356 Target Price 112.50
Oper. Margin - Earnings Date Nov 11 Volume 662,432 Change -4.80%
Healthcare | Biotechnology | United States
About Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Forte Biosciences, Inc. News
11/25/24 Forte Biosciences to Host R&D Day December 3, 2024
11/20/24 Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
11/14/24 Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
10:51 AM Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
08/14/24 Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
05/21/24 Companies Like Forte Biosciences (NASDAQ:FBRX) Could Be Quite Risky
05/17/24 Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
05/13/24 Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
03/18/24 Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wagner Paul A. See Remarks See Remarks Dec 18 Buy 0.7525 10,000 7,525 1,823,236 12/20/23
Wagner Paul A. See Remarks See Remarks Dec 13 Buy 0.71 20,520 14,569 1,813,236 12/15/23
Wagner Paul A. See Remarks See Remarks Dec 11 Buy 0.65 29,776 19,354 1,792,716 12/12/23
Wagner Paul A. See Remarks See Remarks Dec 07 Buy 0.6 51,203 30,722 1,762,940 12/08/23
Wagner Paul A. See Remarks See Remarks Nov 20 Buy 0.43 7,366 3,167 1,711,737 11/22/23